J Hirsh, V Fuster, E Salzman. Show Affiliations »
Abstract
Mesh： See more » Aspirin/administration & dosageAspirin/adverse effectsBlood Platelets/drug effectsClinical Trials as TopicDipyridamole/administration & dosageDipyridamole/adverse effectsDose-Response Relationship, DrugEpoprostenol/administration & dosageEpoprostenol/adverse effectsFibrinolytic Agents/therapeutic useGastric Mucosa/drug effectsHumansSulfinpyrazone/administration & dosageSulfinpyrazone/adverse effects
Substances： See more » Fibrinolytic AgentsDipyridamoleEpoprostenolAspirinSulfinpyrazone
Year: 1986 PMID： 3510829 DOI： 10.1378/chest.89.2_supplement.4s
Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410